Steve Oldham, general counsel and vice president of Roche/courtesy photo Steve Oldham, general counsel and vice president of Roche Diagnostics Corp./courtesy photo
|

Steve Oldham, vice president of law and ethics compliance, general counsel and secretary of Roche Diagnostics Corp., is set to retire after more than three decades in the legal department of one of the world's largest biotech companies, according to a Roche spokesman.

With Oldham slated to retire on April 30, Roche, a multinational Swiss pharmaceutical and medical device company, is on the hunt for his successor.

An ad posted earlier this month states that Roche is hiring a new VP, GC and secretary to oversee legal, ethics and compliance functions at Roche Diagnostics and any subsidiaries and affiliates that are without independent law departments.

“This position is ultimately accountable for the P&L for assigned business areas and will set strategic vision and implement policies and programs to achieve objectives,” the ad states. The new GC and VP also will serve as chief ethics officer of the company to “assure compliance with legal and ethical standards, reduce litigation and improve employee morale.”  

Oldham has not yet released a statement on his retirement and an attempt to speak with him was not immediately successful. He joined Roche Diagnostics in 1988, according his LinkedIn profile. Before he went to work for Roche, Oldham, a Harvard Law School alum, spent more than eight years as assistant GC for another medical tech company, Hillenbrand Industries Inc., now known as Hill-Rom Holdings Inc.

Oldham's successor will be based at Roche's North American headquarters in Indianapolis, where Roche Diagnostics makes equipment that medical providers and researchers use to prevent, diagnose and manage a range of diseases and medical conditions, including HPV, diabetes and hepatitis.

In January, Roche's diagnostic division reported nearly $13 billion in sales for 2018, an increase of about 7 percent over the prior year, due primarily to robust sales of instrument systems, tests, software and services for clinical laboratories.


➤➤ Get in-house news and commentary straight to your inbox with Inside Track, an email briefing from Law.com. Sign up here.